Australian anti-PD-1 therapy to treat advanced melanoma

MSD's anti-PD1 immunotherapy pembrolizumab (trade name KEYTRUDA) has been registered by the Therapeutic Goods Administration (TGA) as monotherapy for the treatment of... [+]

> Posted in Health & medical on 20 April, 2015

Pain trial dosing and new directors at Phosphagenics

Phosphagenics has commenced dosing in a phase 2 clinical trial investigating the safety and efficacy of the drug delivery company's TPM/oxycodone patch in patients... [+]

> Posted in Biotechnology on 17 April, 2015

Govt will pursue a national science policy

The Australian Government has announced its intention to develop a whole-of-government policy for science, technology, engineering and mathematics (STEM).

[+]

> Posted in Lab technology on 15 April, 2015

Better understanding life's blueprint

Two proteins that are involved in ensuring genes are activated at the right time and in the right place are increasing our understanding of early mammalian development. [+]

> Posted in Life sciences on 14 April, 2015

Monitoring moving molecules

Emeritus Professor Philip Kuchel reflects on the moving spectrum of a distinguished career in biochemical research. [+]

> Posted in Life sciences on 07 April, 2015

Latest News

Eureka Prize entries close this week

Entries for the 2015 Australian Museum Eureka Prizes close on Friday, 1 May 2015 at 7 pm AEST. A... [+]

> Posted in Life sciences

Gardasil creators reach European Inventor Award finals

Professor Ian Frazer and Dr Jian Zhou - the creators of the Gardasil HPV vaccine - have been... [+]

> Posted in Life sciences

Minomic prostate cancer test more accurate than PSA

A new trial has revealed that the prostate cancer blood test MiCheck, developed by... [+]

> Posted in Health & medical

$200 million for Medical Research Commercialisation Fund

Brandon Capital Partners, the manager of the Medical Research Commercialisation Fund (MRCF),... [+]

> Posted in Biotechnology

Imugene candidate increases cancer-fighting antibodies

Imugene has found that its lead candidate HER-Vaxx, an immunotherapy product for treatment of... [+]

> Posted in Health & medical

Click here for your FREE subscription

Lab+Life Scientist: The Magazine

Lab+Life Scientist - the magazine for Australia’s scientific and research leaders and innovators. Click for your FREE subscription